AbbVie Logs Another Phase III Success With Tavapadon In Parkinson’s

 
• By Joseph Haas
  
AbbVie has a third successful Phase III trial for tavapadon (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from Therapy Areas